Patents by Inventor Koen Wagner

Koen Wagner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic Anti-CD9 Antibody
    Publication number: 20240360239
    Abstract: The present invention provides novel binding compounds and therapeutic applications thereof.
    Type: Application
    Filed: April 24, 2024
    Publication date: October 31, 2024
    Inventors: Hergen SPITS, Paula Maria Wilhelmina VAN HELDEN, Remko SCHOTTE, Wouter POS, Christien FATMAWATI, Danïel Michiel GO, Koen WAGNER, Julien Christian VILLAUDY
  • Therapeutic anti-CD9 antibody
    Patent number: 11999793
    Abstract: The present invention provides novel binding compounds and therapeutic applications thereof.
    Type: Grant
    Filed: September 16, 2021
    Date of Patent: June 4, 2024
    Assignee: Kling Biotherapeutics B.V.
    Inventors: Hergen Spits, Paula Maria Wilhelmina Van Helden, Remko Schotte, Wouter Pos, Christien Fatmawati, Danïel Michiel Go, Koen Wagner, Julien Christian Villaudy
  • Therapeutic Anti-CD9 Antibody
    Publication number: 20220064323
    Abstract: The present invention provides novel binding compounds and therapeutic applications thereof.
    Type: Application
    Filed: September 16, 2021
    Publication date: March 3, 2022
    Inventors: Hergen SPITS, Paula Maria Wilhelmina VAN HELDEN, Remko SCHOTTE, Wouter POS, Christien FATMAWATI, Danïel Michiel GO, Koen WAGNER, Julien Christian VILLAUDY
  • Therapeutic anti-CD9 antibody
    Patent number: 11136407
    Abstract: The present invention provides novel binding compounds and therapeutic applications thereof.
    Type: Grant
    Filed: January 6, 2017
    Date of Patent: October 5, 2021
    Assignee: AIMM Therapeutics B.V.
    Inventors: Hergen Spits, Paula Maria Wilhelmina Van Helden, Remko Schotte, Wouter Pos, Christien Fatmawati, Danïel Michiel Go, Koen Wagner, Julien Christian Villaudy
  • Means and methods for producing stable antibodies
    Patent number: 10611829
    Abstract: The invention provides means and methods for selecting and producing stable antibodies against an antigen of interest, using stable ex vivo B cell cultures.
    Type: Grant
    Filed: January 30, 2015
    Date of Patent: April 7, 2020
    Assignee: AIMM THERAPEUTICS B.V.
    Inventors: Mark Jeroen Kwakkenbos, Koen Wagner, Adrianus Quirinus Bakker
  • Therapeutic Anti-CD9 Antibody
    Publication number: 20190023803
    Abstract: The present invention provides novel binding compounds and therapeutic applications thereof.
    Type: Application
    Filed: January 6, 2017
    Publication date: January 24, 2019
    Applicant: AIMM Therapeutics B.V.
    Inventors: Hergen SPITS, Paula Maria Wilhelmina VAN HELDEN, Remko SCHOTTE, Wouter POS, Christien FATMAWATI, Danïel Michiel GO, Koen WAGNER, Julien Christian VILLAUDY
  • Means and methods for producing high affinity antibodies
    Patent number: 9969795
    Abstract: The invention provides means and methods for producing high-affinity antibodies against an antigen of interest, usually stable B-cell cultures.
    Type: Grant
    Filed: December 2, 2015
    Date of Patent: May 15, 2018
    Assignee: AIMM THERAPEUTICS B.V.
    Inventors: Tim Beaumont, Mark Jeroen Kwakkenbos, Hergen Spits, Adrianus Quirinus Bakker, Koen Wagner
  • MEANS AND METHODS FOR PRODUCING STABLE ANTIBODIES
    Publication number: 20170008952
    Abstract: The invention provides means and methods for selecting and producing stable antibodies against an antigen of interest, using stable ex vivo B cell cultures.
    Type: Application
    Filed: January 30, 2015
    Publication date: January 12, 2017
    Inventors: Mark Jeroen KWAKKENBOS, Koen WAGNER, Adrianus Quirinus BAKKER
  • MEANS AND METHODS FOR PRODUCING HIGH AFFINITY ANTIBODIES
    Publication number: 20160096881
    Abstract: The invention provides means and methods for producing high-affinity antibodies against an antigen of interest, usually stable B-cell cultures.
    Type: Application
    Filed: December 2, 2015
    Publication date: April 7, 2016
    Inventors: Tim BEAUMONT, Mark Jeroen KWAKKENBOS, Hergen SPITS, Adrianus Quirinus BAKKER, Koen WAGNER
  • Means and methods for producing high affinity antibodies
    Patent number: 9206247
    Abstract: Described are means and methods for producing high-affinity antibodies against an antigen of interest, using stable B-cell cultures.
    Type: Grant
    Filed: December 2, 2011
    Date of Patent: December 8, 2015
    Assignee: AIMM THERAPEUTICS B.V.
    Inventors: Tim Beaumont, Mark Jeroen Kwakkenbos, Hergen Spits, Adrianus Quirinus Bakker, Koen Wagner
  • MEANS AND METHODS FOR PRODUCING HIGH AFFINITY ANTIBODIES
    Publication number: 20130331552
    Abstract: Described are means and methods for producing high-affinity antibodies against an antigen of interest, using stable B-cell cultures.
    Type: Application
    Filed: December 2, 2011
    Publication date: December 12, 2013
    Applicant: AIMM Therapeutics B.V.
    Inventors: Tim Beaumont, Mark Jeroen Kwakkenbos, Hergen Spits, Adrianus Quirinus Bakker, Koen Wagner